Epizyme Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
69.5 M |
Public Float |
39.65 M |
Epizyme Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.64 |
Market Cap |
$1.21 B |
Shares Outstanding |
90.83 M |
Public Float |
58.14 M |
Address |
400 Technology Square Cambridge Massachusetts 02139 United States |
Employees | - |
Website | http://www.epizyme.com |
Updated | 07/08/2019 |
Develops therapeutics for the treatment of patients with genetically defined cancers . |